Dextenza in Pterygium Surgery

Completed · Phase 4

Conditions studied: Pterygium

In brief

DEXTENZA for the treatment of post-surgical pain and inflammation compared to standard of care topical prednisolone acetate 1% in patients who undergo pterygium surgery (excision of pterygium with conjunctival autograft)

Key facts

Study ID

NCT04403516

Run by

Michelle Rhee MD

People needed

30

Starts

2020-10-01

Expected to finish

2021-08-05

Last updated by the study team

2022-04-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A patient's study eye must meet the following criteria to be eligible for inclusion in the study:
• Age of at least 18 years with primary pterygia

You may not qualify if…

• A patient who meets any of the following criteria will be excluded from the study:
• Glaucoma
• Ocular hypertension
• Prior conjunctival surgery
• Other uncontrolled ocular disease
• Ocular surgery in either eye within 3 months
• Use of eye drops other than postoperative medications and artificial tears

Where it is running

• New York Eye Specialists — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.